Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The article says pharmaceutical trials exclude pregnant and nursing participants for ethical reasons, so GLP-1 receptor agonists were never studied in breastfeeding populations during development
Return policy accommodates legitimate research needs while complying with research chemical regulations
Your provider will slowly increase your dose over several months until you attain the maintenance dose
.png.jpg)
The STEP-1 trial data shows the dose-response relationship clearly: 0.25 mg: Minimal weight loss (2-3% over 68 weeks), used only for adaptation 0.5 mg: 6.4% average weight loss 1 mg: 10.9% average weight loss 1.7 mg: 13.8% average weight loss 2.4 mg: 15.8% average weight loss Each escalation produces incremental benefit, but the jumps get smaller as you approach maximum dose
Can I microdose
.png)
